Ranevetmab
Modify Date: 2024-01-24 21:53:56
Ranevetmab structure
|
Common Name | Ranevetmab | ||
|---|---|---|---|---|
| CAS Number | 1632282-27-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RanevetmabRanevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain[1]. |
| Name | Ranevetmab |
|---|
| Description | Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain[1]. |
|---|---|
| Related Catalog | |
| Target |
NGF |
| In Vivo | Ranevetmab (200 μg/kg，静脉注射) 减轻狗的退行性关节病 (DJD) 疼痛[1]。 Animal Model: Dogs with degenerative joint disease (DJD) pain[2] Dosage: 200 μg/kg Administration: i.v. Result: Improved canine brief pain inventory (CBPI), pain severity (PS) and pain interference (PI) scores. |
| References |
| No Any Chemical & Physical Properties |